Emerging Markets Regulatory Tracker: Australia, Brazil (Vol. 4 No. 50)
This article was originally published in PharmAsia News
Executive Summary
Australia’s Therapeutic Goods Administration opens a review of all surgical mesh devices and Brazil plans a look at the regulation of biosimilars.